Condition: Asthma · Sponsor: Enveda Therapeutics
This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants will take oral ENV-294 or placebo once daily for 12 weeks. The study includes a screening period of up to 28 days before randomization to confirm eligibility. Study visits and assessments will be conducted to monitor safety, measure drug levels in the blood, and evaluate effects on asthma control and lung function.
This description comes directly from the study's public registry record.
Clinical Operations · env-294.clinicaltrials@enveda.com
Always discuss trial participation with your own doctor first.
| Enveda Investigative Site | Birmingham, Alabama, United States | Recruiting |
| Enveda Investigative Site | Los Angeles, California, United States | Recruiting |
| Enveda Investigative Site | San Jose, California, United States | Recruiting |
| Enveda Investigative Site | Colorado Springs, Colorado, United States | Recruiting |
| Enveda Investigative Site | Hialeah, Florida, United States | Recruiting |
| Enveda Investigative Site | Albany, Georgia, United States | Recruiting |
| Enveda Investigative Site | Owensboro, Kentucky, United States | Recruiting |
| Enveda Investigative Site | Southfield, Michigan, United States | Recruiting |
| Enveda Investigative Site | St Louis, Missouri, United States | Recruiting |
| Enveda Investigative Site | Clackamas, Oregon, United States | Recruiting |
| Enveda Investigative Site | Medford, Oregon, United States | Recruiting |
| Enveda Investigative Site | North Charleston, South Carolina, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07301255